Biochemical Assay Kits Applications

Kinase drug research has achieved significant progress in the field of targeted therapies, yet numerous new targets and indications remain under investigation. Biochemical and cell-based screening platforms are crucial in kinase drug research. VKEY-BIO provides highly sensitive and high-throughput solutions for developing assays to screening kinase candidate compounds.

Semaglutide's success has sparked significant interest in GPCR research. With many new targets and indications being explored, establishing GPCRs cell-based model for detection and screening GPCR ligands remains a core concern for scientists. VKEY-BIO offers highly sensitive and validated cell-based model for developing assays to screen GPCR candidate compounds.

Cell and gene therapy (CGT) represents a new therapeutic approach, seen as the third revolution in biomedicine. Cell therapy uses transplanted or bioengineered cells, like stem cells or immune cells, to replace damaged cells or enhance immune response. Gene therapy regulates protein levels via gene expression, silencing, or modification, showing great potential for treating refractory diseases. VKEY-BIO offers comprehensive solutions for CGT research, including assay kits for evaluating the efficacy and safety of cell and gene therapies.

Immunology is pivotal in drug development, especially in immunotherapy and vaccine research, targeting cancer and autoimmune diseases. Potent cytokine assays that measure release from immune cells are important for lot release and characterization purposes. VKEY-BIO offers a no-wash cytokines detection solution for Immunology cell-based assay research.

In contrast to small molecule drugs, biologic drugs offer good efficacy and safety with fewer toxic side effects. However, due to their high complexity, the development of biologic drugs requires a comprehensive set of quantitative, accurate, and precise bioanalytical tools. VKEY-BIO offers a series of assay kits for hybridoma and high-yield cell line development, as well as for screening antibody activity.

ADC drug discovery focuses on developing targeted cancer therapies by combining monoclonal antibodies with potent cytotoxic drugs. The aim is to deliver the drug directly to cancer cells while minimizing harm to healthy tissue. VKEY-BIO offers a Cell Viability Detection Kit that can be used to assess the viability of cells treated with ADC drug interventions.